Adrenergic Agonists Bind to Adrenergic-Receptor-Like Regions of the Mu Opioid Receptor, Enhancing Morphine and Methionine-Enkephalin Binding: A New Approach to 'Biased Opioids'?

Autor: Joerg Labahn, Beth Churchill, Udaya Kumar Tiruttani Subhramanyam, Miah Turke, Robert Root-Bernstein
Rok vydání: 2018
Předmět:
0301 basic medicine
Receptors
Opioid
mu

synergy
Adrenergic
mu opioid receptor
Pharmacology
allosteric
lcsh:Chemistry
Mice
Methionine
0302 clinical medicine
Opioid receptor
Receptor
lcsh:QH301-705.5
Spectroscopy
dimerization
Morphine
Chemistry
General Medicine
Adrenergic Agonists
Computer Science Applications
μ-opioid receptor
Histamine
Protein Binding
medicine.drug
Adrenergic receptor
medicine.drug_class
Enkephalin
Methionine

Allosteric regulation
Article
Catalysis
norepinephrine
receptor dimers
Inorganic Chemistry
03 medical and health sciences
Receptors
Adrenergic
alpha-1

ddc:570
Adrenergic antagonist
medicine
methionine-enkephalin
Animals
Humans
biased opioids
Protein Interaction Domains and Motifs
epinephrine
Amino Acid Sequence
Physical and Theoretical Chemistry
enhancement
Molecular Biology
Organic Chemistry
Acetylcholine
morphine
030104 developmental biology
lcsh:Biology (General)
lcsh:QD1-999
Opioid
Spectrophotometry
Ultraviolet

030217 neurology & neurosurgery
Zdroj: International journal of molecular sciences 19(1), 272 (2018). doi:10.3390/ijms19010272
International Journal of Molecular Sciences; Volume 19; Issue 1; Pages: 272
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 19, Iss 1, p 272 (2018)
ISSN: 1422-0067
DOI: 10.3390/ijms19010272
Popis: Extensive evidence demonstrates functional interactions between the adrenergic and opioid systems in a diversity of tissues and organs. While some effects are due to receptor and second messenger cross-talk, recent research has revealed an extracellular, allosteric opioid binding site on adrenergic receptors that enhances adrenergic activity and its duration. The present research addresses whether opioid receptors may have an equivalent extracellular, allosteric adrenergic binding site that has similar enhancing effects on opioid binding. Comparison of adrenergic and opioid receptor sequences revealed that these receptors share very significant regions of similarity, particularly in some of the extracellular and transmembrane regions associated with adrenergic binding in the adrenergic receptors. Five of these shared regions from the mu opioid receptor (muOPR) were synthesized as peptides and tested for binding to adrenergic, opioid and control compounds using ultraviolet spectroscopy. Adrenergic compounds bound to several of these muOPR peptides with low micromolar affinity while acetylcholine, histamine and various adrenergic antagonists did not. Similar studies were then conducted with purified, intact muOPR with similar results. Combinations of epinephrine with methionine enkephalin or morphine increased the binding of both by about half a log unit. These results suggest that muOPR may be allosterically enhanced by adrenergic agonists. View Full-Text Keywords: biased opioids; morphine; methionine-enkephalin; epinephrine; norepinephrine; enhancement; synergy; allosteric; mu opioid receptor; receptor dimers; dimerization
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje